Company intelligence / Profile preview

Nanos Health

Ownership: Private
Development stage: Preclinical

Overview

Nanos Health has developed the Nanostrip™ platform, which uses nanofibers to enable efficient absorption of drugs directly into the bloodstream via an orally dissolvable strip. This approach aims to overcome challenges associated with traditional oral medications such as swallowing difficulties and gastrointestinal side effects. No published clinical results are available as of now[1].

Therapeutic areas: Other
Modalities: Nanoparticle-based drug deliveryNanofiber oral strips (Nanostrip™)
Industry: Consumable Medical Devices

Drug pipeline

1 asset

Nanostrip

Pre-clinical

Beyond the preview

Go deeper on Nanos Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanos Health.

Explore the full profile